Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,110 | 2,029 | 3,087 | 4,402 | 2,342 |
| Receivables | 1,769 | 1,581 | 2,134 | 1,633 | 718 |
| TOTAL | $4,819 | $4,384 | $5,786 | $6,730 | $3,607 |
| Non-Current Assets | |||||
| PPE Net | 3,526 | 3,757 | 5,642 | 5,129 | 3,308 |
| Intangibles | 12,411 | 12,617 | 10,622 | 10,675 | 3,201 |
| Other Non-Current Assets | 4,287 | 4,394 | 3,594 | 3,499 | 1,166 |
| TOTAL | $20,224 | $20,768 | $19,858 | $19,303 | $7,675 |
| Total Assets | $25,043 | $25,152 | $25,644 | $26,033 | $11,282 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,299 | 8,353 | 339 | 157 | N/A |
| Accounts payable and accrued liabilities | 1,996 | 1,679 | 2,103 | 1,763 | 1,206 |
| Accrued Expenses | 6,113 | 5,988 | 2,682 | 2,302 | 1,784 |
| Other current liabilities | 1,729 | 1,329 | 1,524 | 1,495 | 1,244 |
| TOTAL | $17,937 | $18,076 | $7,437 | $6,426 | $4,701 |
| Non-Current Liabilities | |||||
| Long Term Debt | 418 | 469 | 8,379 | 7,760 | N/A |
| Other Non-Current Liabilities | 8,024 | 8,157 | 7,296 | 7,264 | 2,174 |
| TOTAL | $8,373 | $8,626 | $15,675 | $15,024 | $2,174 |
| Total Liabilities | $26,310 | $26,702 | $23,112 | $21,450 | $6,875 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,895 | 13,486 | 8,988 | 7,505 | 5,890 |
| Common Shares | 1 | 1 | 1 | 0 | 0 |
| Retained earnings | -133,039 | -125,357 | -118,464 | -113,064 | -108,051 |
| Other shareholders' equity | -129 | -60 | 0 | 0 | 0 |
| TOTAL | $-1,267 | $-1,550 | $2,532 | $4,583 | $4,407 |
| Total Liabilities And Equity | $25,043 | $25,152 | $25,644 | $26,033 | $11,282 |